nuclear dbf2 (Carna Inc)
Carna Inc is a verified supplier 
Carna Inc manufactures this product 
94
Structured Review
Carna Inc
nuclear dbf2
Nuclear Dbf2, supplied by Carna Inc, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/01-125/NDR1/pm37783115-43-0-15
Average 94 stars, based on 3 article reviews
Nuclear Dbf2, supplied by Carna Inc, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/01-125/NDR1/pm37783115-43-0-15
Average 94 stars, based on 3 article reviews
nuclear dbf2 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Incubation:Article Title: NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells Article Snippet: .. For GTP-pulldown assays, cell lysates were incubated with beads glutathione-S-transferase (GST)-Rhotekin Rho binding domain (RBD), Binding Assay:Article Title: NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells Article Snippet: .. For GTP-pulldown assays, cell lysates were incubated with beads glutathione-S-transferase (GST)-Rhotekin Rho binding domain (RBD), Western Blot:Article Title: NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells Article Snippet: .. For GTP-pulldown assays, cell lysates were incubated with beads glutathione-S-transferase (GST)-Rhotekin Rho binding domain (RBD), Inhibition:Article Title: Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors Article Snippet: Seungil HAN*1, Robert M. CZERWINSKI†, Nicole L. CASPERS*, David C. LIMBURG*, WeiDong DING*, Hong WANG*, Jeffrey F. OHREN*, Francis RAJAMOHAN*, Thomas J. MCLELLAN*, Ray UNWALLA*, Chulho CHOI*, Mihir D. PARIKH*, Nilufer SETH†, Jason EDMONDS†, Chris PHILLIPS*, Subarna SHAKYA†, Xin LI†, Vikki SPAULDING†, Samantha HUGHES*, Andrew COOK*, Colin ROBINSON*, John P. MATHIAS†, Iva NAVRATILOVA†*, Quintus G. MEDLEY†, David R. ANDERSON*, Ravi G. KURUMBAIL*1 and Ann AULABAUGH*1 Targeted Proteomics:Article Title: Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors Article Snippet: Seungil HAN*1, Robert M. CZERWINSKI†, Nicole L. CASPERS*, David C. LIMBURG*, WeiDong DING*, Hong WANG*, Jeffrey F. OHREN*, Francis RAJAMOHAN*, Thomas J. MCLELLAN*, Ray UNWALLA*, Chulho CHOI*, Mihir D. PARIKH*, Nilufer SETH†, Jason EDMONDS†, Chris PHILLIPS*, Subarna SHAKYA†, Xin LI†, Vikki SPAULDING†, Samantha HUGHES*, Andrew COOK*, Colin ROBINSON*, John P. MATHIAS†, Iva NAVRATILOVA†*, Quintus G. MEDLEY†, David R. ANDERSON*, Ravi G. KURUMBAIL*1 and Ann AULABAUGH*1 Generated:Article Title: Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors Article Snippet: Seungil HAN*1, Robert M. CZERWINSKI†, Nicole L. CASPERS*, David C. LIMBURG*, WeiDong DING*, Hong WANG*, Jeffrey F. OHREN*, Francis RAJAMOHAN*, Thomas J. MCLELLAN*, Ray UNWALLA*, Chulho CHOI*, Mihir D. PARIKH*, Nilufer SETH†, Jason EDMONDS†, Chris PHILLIPS*, Subarna SHAKYA†, Xin LI†, Vikki SPAULDING†, Samantha HUGHES*, Andrew COOK*, Colin ROBINSON*, John P. MATHIAS†, Iva NAVRATILOVA†*, Quintus G. MEDLEY†, David R. ANDERSON*, Ravi G. KURUMBAIL*1 and Ann AULABAUGH*1 Concentration Assay:Article Title: Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors Article Snippet: Seungil HAN*1, Robert M. CZERWINSKI†, Nicole L. CASPERS*, David C. LIMBURG*, WeiDong DING*, Hong WANG*, Jeffrey F. OHREN*, Francis RAJAMOHAN*, Thomas J. MCLELLAN*, Ray UNWALLA*, Chulho CHOI*, Mihir D. PARIKH*, Nilufer SETH†, Jason EDMONDS†, Chris PHILLIPS*, Subarna SHAKYA†, Xin LI†, Vikki SPAULDING†, Samantha HUGHES*, Andrew COOK*, Colin ROBINSON*, John P. MATHIAS†, Iva NAVRATILOVA†*, Quintus G. MEDLEY†, David R. ANDERSON*, Ravi G. KURUMBAIL*1 and Ann AULABAUGH*1 |